Forian Inc. · NASDAQ:FORA

Forian — Q1 2023 Earnings Presentation

10 slides from Forian's earnings presentation, May 12, 2023

  1. Slide 1: Q1 2023 Financial Results

    Q1 2023 Financial Results May 12, 2023

  2. Slide 2: Cautionary Statement Regarding Forward-Looking Statements

    Cautionary Statement Regarding Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In

  3. Slide 3: Healthcare Information Revenue Trend

    Healthcare Information Revenue Trend 38% Q1 2023 revenue growth over same quarter last year © 2023 Forian Inc. 3

  4. Slide 4: Revenue and Adjusted EBITDA

    Revenue and Adjusted EBITDA Three Months Ended Period-over- March 31, Period % 2023 2022 Change Unaudited Unaudited Total revenue $ 4,870 $ 3,535 38% Loss from continuing operations, net of tax $ (2,249) $ (10,318) 78% Income (loss) from discontinued operations, net of tax $ 8,747 $ (1,536) 669% Net

  5. Slide 5: Adjusted EBITDA Trend

    Adjusted EBITDA Trend Continued improvement in Adjusted EBITDA loss driven by revenue growth and cost management Adjusted EBITDA is a non-U.S. GAAP measure. See Appendix for further information, including a reconciliation of Adjusted EBITDA to Net Loss. © 2023 Forian Inc. 5

  6. Slide 6: Summary Balance Sheet Data

    Summary Balance Sheet Data March 31, 2023 Cash and equivalents $40,004 Proceeds receivable – sale of discontinued operations $ 8,812 Net working capital $45,770 Convertible note and accrued interest (due 9/2025) $25,315 Shares outstanding 32,419 © 2023 Forian Inc. 6

  7. Slide 7: Summary Balance Sheet and Cash Flow

    Summary Balance Sheet and Cash Flow Balance Sheet Cash Flows from Continuing Operations $000's 31-Mar-23 $000's 31-Mar-23 CASH FLOWS FROM OPERATIONS Loss from continuing operations $ (2,249) Cash & marketable securities $ 40,004 Depreciation & amortization 38 • Well capitalized to Other current asse

  8. Slide 8: Full Year 2023 Outlook

    Full Year 2023 Outlook Expect 2023 Healthcare Information Revenue growth of 25% to 37% resulting in revenue in the range of $20.5 to $22.5 million Continued Improvement in Adjusted EBITDA (1), reaching positive Adjusted EBITDA contribution in the second half of 2023 The outlook provided above consti

  9. Slide 9: Q&A

    Q&A © 2023 Forian Inc. 9

  10. Slide 10: © 2023 Forian Inc.

    © 2023 Forian Inc.

Forian — Q1 2023 Earnings Presentation on 6ix